| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-05-16 | 2017-07-20 | 10439 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-11-01 | 2018-02-17 | 27770 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2020-11-04 | 2020-12-31 | 127762 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2021-03-05 | 2021-06-14 | 135181 |
| APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2023-11-06 | 2023-11-10 | 209357 |
| AA-AMILZIDE | 50MG 5MG | TABLET | Resolved | 2017-06-05 | 2017-06-14 | 11956 |
| AA-AMILZIDE | 50MG 5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69296 |
| AA-AMILZIDE | 50MG 5MG | TABLET | Resolved | 2017-10-23 | 2018-07-11 | 26557 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Resolved | 2017-12-14 | 2018-02-26 | 32772 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-11-07 | 2018-02-26 | 28539 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2019-04-10 | 2019-04-11 | 81148 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| TEVA-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258759 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |